Business Context and Reporting Period
This Form 8-K Current Report was filed by Inogen, Inc. on January 11, 2016. The filing serves as a Regulation FD disclosure regarding upcoming investor presentations and the release of an updated investor slide deck.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses on the dissemination of an updated presentation rather than reporting specific financial results for a period.
Material Changes
The filing notes the inclusion of an updated inside sales representative headcount within the attached investor presentation. No other material changes to financial position or operations are detailed in the text of this report.
Guidance, Outlook, and Management Commentary
Management officers are scheduled to present at the J.P. Morgan 34th Annual Healthcare Conference (January 12-13, 2016) and the 18th Annual Needham Growth Conference (January 13, 2016). An updated slide presentation (Exhibit 99.1) containing the new headcount data is available on the company website. Live audio webcasts of these presentations were scheduled for January 13, 2016. The filing explicitly states that the information contained herein is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the updated inside sales representative headcount in Exhibit 99.1.
- Review the full investor presentation available on www.inogen.com for detailed operational updates.
- Confirm the timing and availability of the live audio webcasts for the J.P. Morgan and Needham conferences.
- Note that this 8-K does not contain audited financial statements or specific revenue figures.